Article History
Received: 29 April 2019
Accepted: 2 March 2021
First Online: 19 March 2021
Declarations
:
: Institutional review board approval was granted by Connecticut Children’s Medical Center (CCMC) in Hartford Connecticut. The research was judged exempt from review and consent was not required due to the nature of it being a retrospective study of non-identified data.
: Not applicable.
: Not applicable.
: NB is a speaker/consultant for Horizon Pharma (maker of Actimmune) and has clinical trial support from Baxalta (makers of Gammagard, Cuvitru and Hyqvia). SS and TJ have no conflicts of interest.